|
|
Blood, 1 August 2004, Vol. 104, No. 3, pp. 675-686.
Prepublished online as a Blood First Edition Paper on April 13, 2004; DOI 10.1182/blood-2003-10-3423.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis
Wolfgang Wagner,
Alexandra Ansorge,
Ute Wirkner,
Volker Eckstein,
Christian Schwager,
Jonathon Blake,
Katrin Miesala,
Jan Selig,
Rainer Saffrich,
Wilhelm Ansorge, and
Anthony D. Ho
From the Department of Medicine V, University of Heidelberg, Heidelberg, Germany; and Biochemical Instrumentation Programme, European Molecular Biology Laboratory, Heidelberg, Germany.
The molecular mechanisms that regulate asymmetric divisions of hematopoietic progenitor cells (HPCs) are not yet understood. The slow-dividing fraction (SDF) of HPCs is associated with primitive function and self-renewal, whereas the fast-dividing fraction (FDF) predominantly proceeds to differentiation. CD34+/CD38 cells of human umbilical cord blood were separated into the SDF and FDF. Genomewide gene expression analysis of these populations was determined using the newly developed Human Transcriptome Microarray containing 51 145 cDNA clones of the Unigene Set-RZPD3. In addition, gene expression profiles of CD34+/CD38 cells were compared with those of CD34+/CD38+ cells. Among the genes showing the highest expression levels in the SDF were the following: CD133, ERG, cyclin G2, MDR1, osteopontin, CLQR1, IFI16, JAK3, FZD6, and HOXA9, a pattern compatible with their primitive function and self-renewal capacity. Furthermore, morphologic differences between the SDF and FDF were determined. Cells in the SDF have more membrane protrusions and CD133 is located on these lamellipodia. The majority of cells in the SDF are rhodamine-123dull. These results provide molecular evidence that the SDF is associated with primitive function and serves as basis for a detailed understanding of asymmetric division of stem cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Stem cells and the Heisenberg uncertainty principle
- H. Jeffrey Lawrence
Blood 2004 104: 597-598.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
F. P. G. Silva, S. M. A. Swagemakers, C. Erpelinck-Verschueren, B. J. Wouters, R. Delwel, H. Vrieling, P. van der Spek, P. J. M. Valk, and M. Giphart-Gassler
Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status
Blood,
October 1, 2009;
114(14):
3001 - 3007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kandilci and G. C. Grosveld
Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation
Blood,
August 20, 2009;
114(8):
1596 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Barcelos, C. Duplaa, N. Krankel, G. Graiani, G. Invernici, R. Katare, M. Siragusa, M. Meloni, I. Campesi, M. Monica, et al.
Human CD133+ Progenitor Cells Promote the Healing of Diabetic Ischemic Ulcers by Paracrine Stimulation of Angiogenesis and Activation of Wnt Signaling
Circ. Res.,
May 8, 2009;
104(9):
1095 - 1102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-L. Wu, C. Zierold, and E. A. Ranheim
Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia
Blood,
March 26, 2009;
113(13):
3031 - 3039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Guenther, L. N. Lawton, T. Rozovskaia, G. M. Frampton, S. S. Levine, T. L. Volkert, C. M. Croce, T. Nakamura, E. Canaani, and R. A. Young
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
Genes & Dev.,
December 15, 2008;
22(24):
3403 - 3408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Meester-Smoor, M. J.F.W. Janssen, G. C. Grosveld, A. de Klein, W. F.J. van IJcken, H. Douben, and E. C. Zwarthoff
MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression
Carcinogenesis,
October 1, 2008;
29(10):
2025 - 2034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Langer, M. D. Radmacher, A. S. Ruppert, S. P. Whitman, P. Paschka, K. Mrozek, C. D. Baldus, T. Vukosavljevic, C.-G. Liu, M. E. Ross, et al.
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study
Blood,
June 1, 2008;
111(11):
5371 - 5379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Araki, K. Yoshinaga, P. Boccuni, Y. Zhao, R. Hoffman, and N. Mahmud
Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential
Blood,
April 15, 2007;
109(8):
3570 - 3578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Keller, S. Addya, R. Vadigepalli, B. Banini, K. Delgrosso, H. Huang, and S. Surrey
Transcriptional regulatory network analysis of developing human erythroid progenitors reveals patterns of coregulation and potential transcriptional regulators
Physiol Genomics,
December 13, 2006;
28(1):
114 - 128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Heuser, G. Beutel, J. Krauter, K. Dohner, N. von Neuhoff, B. Schlegelberger, and A. Ganser
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics
Blood,
December 1, 2006;
108(12):
3898 - 3905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dykstra, J. Ramunas, D. Kent, L. McCaffrey, E. Szumsky, L. Kelly, K. Farn, A. Blaylock, C. Eaves, and E. Jervis
High-resolution video monitoring of hematopoietic stem cells cultured in single-cell arrays identifies new features of self-renewal
PNAS,
May 23, 2006;
103(21):
8185 - 8190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Wang, M. P. Pasillas, and M. P. Kamps
Persistent Transactivation by Meis1 Replaces Hox Function in Myeloid Leukemogenesis Models: Evidence for Co-Occupancy of Meis1-Pbx and Hox-Pbx Complexes on Promoters of Leukemia-Associated Genes
Mol. Cell. Biol.,
May 15, 2006;
26(10):
3902 - 3916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rainis, T. Toki, J. E. Pimanda, E. Rosenthal, K. Machol, S. Strehl, B. Gottgens, E. Ito, and S. Izraeli
The Proto-Oncogene ERG in Megakaryoblastic Leukemias
Cancer Res.,
September 1, 2005;
65(17):
7596 - 7602.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|